Califf RM - Search Results

1

Economic return of clinical trials performed under the pediatric exclusivity program.

Li JS, Eisenstein EL, Grabowski HG, Reid ED, Mangum B, Schulman KA, Goldsmith JV, Murphy MD, Califf RM, Benjamin DK Jr. Li JS, et al. Among authors: califf rm. JAMA. 2007 Feb 7;297(5):480-8. doi: 10.1001/jama.297.5.480. JAMA. 2007. PMID: 17284698 Free PMC article.

2

Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease.

Williams RB, Barefoot JC, Califf RM, Haney TL, Saunders WB, Pryor DB, Hlatky MA, Siegler IC, Mark DB. Williams RB, et al. Among authors: califf rm. JAMA. 1992 Jan 22-29;267(4):520-4. JAMA. 1992. PMID: 1729574

3

How should clinicians interpret clinical trials?

Califf RM. Califf RM. Cardiol Clin. 1995 Aug;13(3):459-68. Cardiol Clin. 1995. PMID: 7585780

4

Importance of cost and quality of life in decisions about routine angiography after acute myocardial infarction. The role of cost-effectiveness models.

Eisenstein EL, Mark DB, Califf RM. Eisenstein EL, et al. Among authors: califf rm. Circulation. 1996 Sep 1;94(5):869-71. doi: 10.1161/01.cir.94.5.869. Circulation. 1996. PMID: 8790017 No abstract available.

5

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

Califf RM, Adams KF, McKenna WJ, Gheorghiade M, Uretsky BF, McNulty SE, Darius H, Schulman K, Zannad F, Handberg-Thurmond E, Harrell FE Jr, Wheeler W, Soler-Soler J, Swedberg K. Califf RM, et al. Am Heart J. 1997 Jul;134(1):44-54. doi: 10.1016/s0002-8703(97)70105-4. Am Heart J. 1997. PMID: 9266782 Clinical Trial.

6

Assessing the value of newer pharmacologic agents in non-ST elevation patients: a decision support system application.

Eisenstein EL, Peterson ED, Jollis JG, Tardiff BE, Califf RM, Knight JD, Mark DB. Eisenstein EL, et al. Among authors: califf rm. Proc AMIA Annu Fall Symp. 1997:273-7. Proc AMIA Annu Fall Symp. 1997. PMID: 9357631 Free PMC article.

7

Developing systems for cost-effective auditing of clinical trials.

Califf RM, Karnash SL, Woodlief LH. Califf RM, et al. Control Clin Trials. 1997 Dec;18(6):651-60; discussion 661-6. doi: 10.1016/s0197-2456(96)00237-1. Control Clin Trials. 1997. PMID: 9408727 Review.

8

Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.

Hathaway WR, Peterson ED, Wagner GS, Granger CB, Zabel KM, Pieper KS, Clark KA, Woodlief LH, Califf RM. Hathaway WR, et al. Among authors: califf rm. JAMA. 1998 Feb 4;279(5):387-91. doi: 10.1001/jama.279.5.387. JAMA. 1998. PMID: 9459474

9

Outcomes and costs within a disease management program for advanced congestive heart failure.

Schulman KA, Mark DB, Califf RM. Schulman KA, et al. Among authors: califf rm. Am Heart J. 1998 Jun;135(6 Pt 2 Su):S285-92. doi: 10.1016/s0002-8703(98)70256-x. Am Heart J. 1998. PMID: 9630091 Free article. Review. No abstract available.

10

Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.

Alexander JH, Sparapani RA, Mahaffey KW, Deckers JW, Newby LK, Ohman EM, Corbalán R, Chierchia SL, Boland JB, Simoons ML, Califf RM, Topol EJ, Harrington RA. Alexander JH, et al. Among authors: califf rm. JAMA. 2000 Jan 19;283(3):347-53. doi: 10.1001/jama.283.3.347. JAMA. 2000. PMID: 10647797

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,321 results

Search Page